SUMMARY An 8 year old girl with ocular myasthenia gravis was treated with high dose intravenous immunoglobulin and high dose intravenous methyl-prednisolone. Ocular symptoms recurred seven months after the start of the immunoglobulin. She has been in remission for more than 12 months after two courses of intravenous methylprednisolone, and administration of oral prednisolone was discon-tinued. Recently, high dose intravenous immunoglobulin and high dose intravenous methylprednisolone have been reported to improve the symptoms of general-ised myasthenia gravis. 2 We have treated a patient with ocular myasthenia gravis refractory to several anticholinesterase compounds and oral predniso
Myasthenia gravis is a disease affecting the neuromuscular junction. Still today it is not very clea...
Myasthenia gravis is caused by pathogenic autoantibodies to the postsynaptic neuromuscular junction....
To describe the clinical characteristics and outcomes in patients with refractory myasthenia gravis ...
A 7-year-old girl with ocular myasthenia gravis (MG) refractory to prednisolone and anticholinestera...
Ocular myasthenia gravis is a chronic disease generally requiring years of treatment. Treatment cons...
Substantial therapeutic progress has been made in myasthenia gravis (MG) even before the era of mole...
Juvenile myasthenia gravis is a rare acquired disease of childhood. It is difficult to differentiate...
Myasthenia gravis (MG) is an autoimmune disease in which antibodies are directed against the postsyn...
The prognosis of myasthenia gravis (MG) has improved dramatically due to advances in critical-care m...
Purpose: This is a case of myasthenic incomplete ophthalmoplegia mimicking a partial cranial nerve 3...
Myasthenia gravis (MG) is an autoimmune disease of the neuromuscular junction, due to the binding of...
Abstract: Substantial therapeutic progress has been made in myasthenia gravis (MG) even before the e...
The prognosis for patients with myasthenia gravis (MG) has improved significantly over the past half...
Myasthenia gravis (MG) is an autoimmune disease, which can be triggered by anticholinergic agents. T...
Immunosuppression is the mainstay of treatment for myasthenia gravis (MG). In this paper, we review ...
Myasthenia gravis is a disease affecting the neuromuscular junction. Still today it is not very clea...
Myasthenia gravis is caused by pathogenic autoantibodies to the postsynaptic neuromuscular junction....
To describe the clinical characteristics and outcomes in patients with refractory myasthenia gravis ...
A 7-year-old girl with ocular myasthenia gravis (MG) refractory to prednisolone and anticholinestera...
Ocular myasthenia gravis is a chronic disease generally requiring years of treatment. Treatment cons...
Substantial therapeutic progress has been made in myasthenia gravis (MG) even before the era of mole...
Juvenile myasthenia gravis is a rare acquired disease of childhood. It is difficult to differentiate...
Myasthenia gravis (MG) is an autoimmune disease in which antibodies are directed against the postsyn...
The prognosis of myasthenia gravis (MG) has improved dramatically due to advances in critical-care m...
Purpose: This is a case of myasthenic incomplete ophthalmoplegia mimicking a partial cranial nerve 3...
Myasthenia gravis (MG) is an autoimmune disease of the neuromuscular junction, due to the binding of...
Abstract: Substantial therapeutic progress has been made in myasthenia gravis (MG) even before the e...
The prognosis for patients with myasthenia gravis (MG) has improved significantly over the past half...
Myasthenia gravis (MG) is an autoimmune disease, which can be triggered by anticholinergic agents. T...
Immunosuppression is the mainstay of treatment for myasthenia gravis (MG). In this paper, we review ...
Myasthenia gravis is a disease affecting the neuromuscular junction. Still today it is not very clea...
Myasthenia gravis is caused by pathogenic autoantibodies to the postsynaptic neuromuscular junction....
To describe the clinical characteristics and outcomes in patients with refractory myasthenia gravis ...